Abstract
The diversity of probiotic products makes choosing an appropriate probiotic challenging. One unanswered question is whether single-strain probiotics are more effective than multi-strain mixtures. The aim of this review is to account for both disease and strain specificity to determine whether single strains or multiple strains are equivalent or more effective. This literature review of randomized controlled trials from 1973 to 2019 was used to compare the pooled efficacy of trials with a single strain versus the probiotic mixture with same matched strain within the same type of disease indication. A total of 65 RCTs were included (41 with single strains, 22 multi-strain mixtures and 2 comparing single strain to mixture arms) for eight different disease indications (N = 10,863). Only three strains (L. rhamnosus GG, L. helveticus R52 and B. lactis Bb12) had corresponding trials with matching mixtures. Use of L. rhamnosus GG only was significantly more protective for necrotizing enterocolitis compared to two mixtures also containing different strains of B. lactis. The mixture of L. rhamnosus GG and B. lactis Bb12 was significantly more effective than L. rhamnosus GG alone for the eradication of H. pylori. In most cases, single strains were equivalent to mixtures. Choice of an appropriate probiotic should be based, not on the number of strains in the product, rather based on evidence-based trials of efficacy. In most cases, multi-strain mixtures were not significantly more effective than single-strain probiotics.
Similar content being viewed by others
References
Sniffen JC, McFarland LV, Evans CT, et al. Choosing an appropriate probiotic product for your patient: an evidence-based practical guide. Including S1. Dataset. McFarland dataset for probiotic trials. PLOS ONE. 2018;13:e0209205.
Szajewska H. Pooling data on different probiotics is not appropriate to assess the efficacy of probiotics. Eur J Pediatr. 2014;173:975.
Ouwehand AC, Isolauri E, Kirjavainen PV, et al. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol. 2000;30:10–13.
Timmerman HM, Koning CJ, Mulder L, et al. Monostrain, multistrain and multispecies probiotics-a comparison of functionality and efficacy. Int J Food Microbiol. 2004;96:219–233.
Medina M, Izquierdo E, Ennahar S, et al. Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol. 2007;150:531–538.
Mileti E, Matteoli G, Iliev ID, et al. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE. 2009;4:e7056.
Chapman CMC, Gibson GR, Rowland I. In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe. 2012;18:405–413.
Fredua-Agyeman M, Stapleton P, Basit AW, et al. Microcalorimetric evaluation of a multi-strain probiotic: interspecies inhibition between probiotic strains. J Funct Foods. 2017;36:356–361.
Forssten SD, Ouwehand AC. Simulating colonic survival of probiotics in single-strain products compared to multi-strain products. Microb Ecol Health Dis. 2017;28:1378061.
Korada SK, Yarla NS, Mishra V, et al. Single probiotic versus multiple probiotics—a debate on current scenario for alleviating health benefits. Curr Pharm Des. 2018;24:4150–4153.
Ouwehand AC, Invernici MM, Furlaneto FAC, et al. Effectiveness of multistrain versus single-strain probiotics: current status and recommendations for the future. J Clin Gastroenterol. 2018;52:S35–S40.
Goldenberg JZ, Lytvyn L, Steurich J, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;4:CD004827.
Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157:878–888.
Chang HY, Chen JH, Chang JH, et al. Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: an updated meta-analysis. PLoS ONE. 2017;12:e0171579.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
McFarland LV, Elmer GW, McFarland M. Meta-analysis of probiotics for the prevention and treatment of acute pediatric diarrhea. Int J Probiot Prebiot. 2006;1:63–76.
McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol. 2008;14:2650–2661.
McFarland LV, Goh S. Preventing pediatric antibiotic-associated diarrhea and Clostridium difficile infections with probiotics: a meta-analysis. World J Meta-Anal. 2013;1:102–120.
McFarland LV, Malfertheiner P, Huang Y, et al. Meta-analysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events. World J Meta-Anal. 2015;3:97–117.
McFarland LV, Huang Y, Wang L, et al. Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United Euro J Gastroenterol. 2016;4:546–561.
Feng JR, Wang F, Qiu X, et al. Efficacy and safety of probiotics supplemented triple therapy for eradication of Helicobacter pyloriin children: a systematic review and network meta-analysis. Euro J Clin Pharm. 2017;73:1199–1208.
Agamennone V, Krul CAM, Rijkers G, et al. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. BMC Gastroenterol. 2018;18:103.
McFarland LV, Goh S. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: a systematic review and meta-analysis. Trav Med Infect Dis. 2019;27:11–19.
Hill C, Guarner F, Reid G, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–514.
McFarland LV, Evans CT, Goldstein EJC. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front Med. 2018;5:1–14.
Palmer TM, Sterne JAC, eds. Meta-analysis in Stata: an updated collection from the Stata Journal. 2nd ed. College Station: Stata Press; 2016.
Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Altman DG, Bland JM. Statistics notes interaction revisited: the difference between two estimates. BMJ. 2003;326:219.
Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60:494–500.
Hays S, Jacquot A, Gauthier H, et al. Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study. Clin Nutr. 2016;35:802–811. https://doi.org/10.1016/j.clnu.2015.06.
Vaisanen ML, Leskinen M, Siitonen A, et al. Occurrence of diarrhea in children receiving oral antibiotics with or without probiotic supplementation with Lactobacillus GG. Microbiol Ecol Health Dis. 1998;10:199–200.
Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564–568.
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64.
Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion. 2001;63:1–7.
Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2001;15:163–169.
Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc. 2001;76:883–889.
Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol. 2002;97:2744–2749.
Miller M, Florencio S, Eastmond J, et al. Results of 2 prospective randomized studies of Lactobacillus GG to prevent C. difficile infection in hospitalized adults receiving antibiotics. Intersci Conf Antimicrobial Agents Chemother. 2008;48:578–579.
Szajewska H, Albrecht P, Topczewska-Cabanek A. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr. 2009;48:431–436.
Padilla-Ruiz M, Fernández Aguiar ME, Arce Nuñez M, et al. Lactobacillus rhamnosus GG supplementation to reduce side-effects of anti-Helicobacter pylori treatment. Rev Gastroenterol Peru. 2013;33:121–130.
Hauser G, Salkic N, Vukelic K, et al. Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2015;94:e685.
Wenus C, Goll R, Loken EB, et al. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr. 2008;62:299–301.
Fox MJ, Ahuja KD, Robertson IK, et al. Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open. 2015;5:e006474.
Myllyluoma E, Veijola L, Ahlroos T, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy—a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther. 2005;21:1263–1272.
Ivanko O, Radutnaya E. Lactobacillus acidophilus reduces frequency of diarrhoea caused by toxins Clostridium difficile A + B in children treated by antibiotics. Zaporozhye Med Period. 2005;2:21–23.
Marushko Y, Shef G. Current status of antibiotics-associated bowel disorders issue in children. Perinatol Paediatr. 2007;4:65–68.
Gnaytenko O, Lychkovska O, Kulachkovska Y, et al. Antibiotic-associated diarrhoea as a complication of anti-helicobacter therapy in children. Pract Med. 2009;5:76–83.
Aryayev M, Kononenko N. Prevention of antibiotic-associated diarrhoea in patients with cystic fibrosis. Odessa Med J. 2009;4:78.
Song H, Kim J, Jung S, et al. Effect of probiotic Lactobacillus (Lacidofil® Cap) for the prevention of antibiotic-associated diarrhoea: a prospective, randomised double-blind multicenter study. J Korean Med Sci. 2010;25:1784–1791.
Liskovich V, Naumov I, Ganchar E, et al. Efficiency of Lacidofil-WM for prevention of vaginal dysbiosis and antibiotics-associated diarrhoea in puerperas after caesarean operation. Health. 2010;1:63–66.
Evans M, Salewski RP, Christman MC, et al. Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2016;116:94–103.
Grgov S, Tasić T, Radovanović-Dinić B, et al. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study. Vojnosanit Pregl. 2016;73:1044–1049.
Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179–185.
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604–1610.
Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003;36:223–227.
Fölster-Holst R, Müller F, Schnopp N, et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol. 2006;155:1256–1261.
Grüber C, Keil T, Kulig M, et al. History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol. 2007;62:1270–1276.
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001;357:1076–1079.
Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy. 2002;57:243–246. https://doi.org/10.1034/j.1398-9995.2002.1s3299.x.
Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850–e856.
Cabana MD, McKean M, Caughey AB, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics. 2017;140:e20163000. https://doi.org/10.1542/peds.2016-3000.
Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192–198.
Simpson MR, Dotterud CK, Storrø O, Johnsen R, Øien T. Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol. 2015;15:13. https://doi.org/10.1186/s12895-015-0030-1.
Dotterud CK, Storrø O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616–623. https://doi.org/10.1111/j.1365-2133.2010.09889.x.
Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr. 2005;147:197–201. https://doi.org/10.1016/j.jpeds.2005.05.015.
Gawrońska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007;25:177–184. https://doi.org/10.1111/j.1365-2036.2006.03175.x.
Francavilla R, Miniello V, Magistà AM, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010;126:e1445–e1452. https://doi.org/10.1542/peds.2010-0467.
Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6 month intervention. Aliment Pharmacol Ther. 2005;22:387–394.
Mohan R, Koebnick C, Schildt J, et al. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol. 2006;44:4025–4031.
Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology. 2010;98:156–163. https://doi.org/10.1159/000280291.
Lambæk ID, Fonnest G, Gormsen M, Brok J, Greisen G. Probiotics to prevent necrotising enterocolitis in very preterm infants. Dan Med J. 2016;63:A5203.
Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82:103–108.
Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis. 2006;42:1735–1742. https://doi.org/10.1086/504324.
Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA. 2009;302:1421–1428. https://doi.org/10.1001/jama.2009.1403.
Manzoni P, Meyer M, Stolfi I, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev. 2014;90:S60–S65. https://doi.org/10.1016/S0378-3782(14)70020-9.
Rougé C, Piloquet H, Butel MJ, et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2009;89:1828–1835. https://doi.org/10.3945/ajcn.2008.26919.
Van Niekerk E, Nel DG, Blaauw R, Kirsten GF. Probiotics reduce necrotizing enterocolitis severity in HIV-exposed premature infants. J Trop Pediatr. 2015;61:155–164. https://doi.org/10.1093/tropej/fmv004.
Ziegler EE, Jeter JM, Drulis JM, et al. Formula with reduced content of improved, partially hydrolyzed protein and probiotics: infant growth and health. Monatsschrift Kinderheilkunde. 2003;151:S65–S71.
Barclay D, Giammanco A, Carrie-Fassler AL, et al. Growth and tolerance of whey-based starter infant formula with enhanced protein efficiency and containing pro-, pre- or synbiotics: a randomized controlled trial in term infants. J Pediatr Gastroenterol Nutr. 2003;37:388.
Urban MF, Bolton KD, Mokhachane M, et al. Growth of infants born to HIV-infected women when fed a biologically acidified starter formula with and without probiotics. S Afr J Clin Nut. 2008;21:28–32.
Gibson RA, Barclay D, Marshall H, et al. Safety of supplementing infant formula with long- chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. Br J Nutr. 2009;101:1706–1713. https://doi.org/10.1017/S0007114508084080.
Cooper P, Bolton KD, Velaphi S, et al. Early benefits of a starter formula enriched in prebiotics and probiotics on the gut microbiota of healthy infants born to HIV+ mothers: a randomized double-blind controlled trial. Clin Med Insights Pediatr. 2017;10:119–130. https://doi.org/10.4137/CMPed.S40134.
Mantaring J, Benyacoub J, Destura R, et al. Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines. BMC Pregnancy Childbirth. 2018;18:193. https://doi.org/10.1186/s12884-018-1828-8.
Taipale T, Pienihäkkinen K, Isolauri E, et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr. 2011;105:409–416. https://doi.org/10.1017/s0007114510003685.
Hatakka K, Savilahti E, Pönkä A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322:1327.
Honeycutt TC, El Khashab M, Wardrop RM 3rd, et al. Probiotic administration and the incidence of nosocomialinfection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med. 2007;8:452–458. https://doi.org/10.1097/01.PCC.0000282176.41134.E6.
Hojsak I, Snovak N, Abdović S, et al. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2010;29:312–316. https://doi.org/10.1016/j.clnu.2009.09.008.
Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182:1058–1064. https://doi.org/10.1164/rccm.200912-1853OC.
Kumpu M, Kekkonen RA, Korpela R, et al. Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial. Benef Microbes. 2015;6:631–639. https://doi.org/10.3920/bm2014.0164.
Luoto R, Ruuskanen O, Waris M, Kalliomäki M, Salminen S, Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. Allergy Clin Immunol. 2014;133:405–413. https://doi.org/10.1016/j.jaci.2013.08.020.
Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy—a randomised, double-blind, placebo-controlled study. Br J Nutr. 2009;101:1722–1726. https://doi.org/10.1017/S0007114508116282.
Smith TJ, Rigassio-Radler D, Denmark R, Haley T, Touger-Decker R. Effect of Lactobacillusrhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013;109:1999–2007. https://doi.org/10.1017/s0007114512004138.
Lehtoranta L, Kalima K, He L, et al. Specific probiotics and virological findings in symptomatic conscripts attending military service in Finland. J Clin Virol. 2014;60:276–281. https://doi.org/10.1016/j.jcv.2014.03.021.
Chapman CMC, Gibson GR, Rowland I. Effects of single- and multi-strain probiotics on biofilm formation and in vitro adhesion to bladder cells by urinary tract pathogens. Anaerobe. 2014;27:71–76.
Chapman C, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective single strains? Euro J Nutr. 2011;50:1–17.
Bisson JF, Hidalgo S, Rozan P, et al. Preventive effects of different probiotic formulations on travelers’ diarrhea model in Wistar rats: preventive effects of probiotics on TD. Dig Dis Sci.. 2010;55:911–919. https://doi.org/10.1007/s10620-009-0822-4.
Funding
This study was unfunded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
LVM is on the Scientific Advisory Board and paid consultant for Bio-K+ (Canada) and on the Microbiome Advisory Board and paid consultant for Biocodex (France) but owns no stock or equity in either company.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
McFarland, L.V. Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity. Dig Dis Sci 66, 694–704 (2021). https://doi.org/10.1007/s10620-020-06244-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-020-06244-z